About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Announces Launch of Epic Integration for clonoSEQ® 09-13-2023 at 7:31 AM EDT Adaptive Biotechnologies to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference 08-30-2023 at 4:30 PM EDT Adaptive Biotechnologies Reports Second Quarter 2023 Financial Results 08-02-2023 at 4:07 PM EDT VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations Morgan Stanley 21st Annual Global Healthcare Conference Sep 13, 2023 at 1:35 PM EDT Listen to webcast Adaptive Biotechnologies Second Quarter Financial Results Aug 2, 2023 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Q2 2023 Earnings Presentation 1.2 MB Goldman Sachs 44th Annual Global Healthcare Conference Jun 12, 2023 at 7:00 PM EDT Listen to webcast VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Sep 26, 2023 7:38 AM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.
